HI homepage

Breast cancer AI ribbon pink artificial intelligence

In clinical testing, the module achieved 90% sensitivity and 88% specificity across patients with varying levels of breast density. 

Midjourney ultrasound scanning whole-body ultrasonic CT

Radiologists, meanwhile, took to social media to criticize the endeavor, noting that the generative AI company lacks clinical evidence to back its marketing claims. 

The proportion of radiologists performing some (>0%) IR-related work declined from 70% in 2008 down to 50% by 2023, according to new research published in JVIR. 

lung cancer screening low-dose CT

While overall lung cancer rates are declining, cases among nonsmoking women are on the rise, puzzling scientists.   

Thumbnail

These findings come amid ongoing efforts to reduce the amount of gadolinium in MRI contrast agents.

Physician warning

Some of the company’s ventilators have been designed for use in MRI settings, but a recent FDA inspection raises questions about these claims. 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.